Global Angiotensin Converting Enzyme (ACE) Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published: September 2022

No. of Pages: 118

Price:

Single User License: US $ 5600

Corporate User License: US $ 11200

Report Description
Table of Contents

Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Angiotensin Converting Enzyme (ACE) Inhibitors manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Angiotensin Converting Enzyme (ACE) Inhibitors market. Further, it explains the major drivers and regional dynamics of the global Angiotensin Converting Enzyme (ACE) Inhibitors market and current trends within the industry.

Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- Abbott Laboratories
- Pfizer
- Novartis
- Merck
- Astra Zeneca
- Jhonson and Johnson
- Eli Lilly
- Sanofi
- Bristol-Myers Squibb
- Bayer
- GSK
- Teva Pharmaceutical

Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Type
- Sulfhydryl-containing Agents
- Dicarboxylate-containing Agents
- Phosphonate-containing Agents
Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Application
- Hypertension
- Cardiovascular Diseases
- Kidney Diseases
- Other

Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Angiotensin Converting Enzyme (ACE) Inhibitors market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:
This report presents an overview of global market for Angiotensin Converting Enzyme (ACE) Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Angiotensin Converting Enzyme (ACE) Inhibitors, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Angiotensin Converting Enzyme (ACE) Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Angiotensin Converting Enzyme (ACE) Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Angiotensin Converting Enzyme (ACE) Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Angiotensin Converting Enzyme (ACE) Inhibitors sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi and Bristol-Myers Squibb, etc.

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Sulfhydryl-containing Agents
1.2.3 Dicarboxylate-containing Agents
1.2.4 Phosphonate-containing Agents
1.3 Market Segment by Application
1.3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size (2017-2028)
2.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2017-2028)
2.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (2017-2028)
2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Regions (2017-2022)
2.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Regions (2017-2022)
2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Region
2.3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Region (2023-2028)
2.3.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast by Region (2023-2028)
2.4 Global Top Angiotensin Converting Enzyme (ACE) Inhibitors Regions (Countries) Ranking by Market Size
2.5 Angiotensin Converting Enzyme (ACE) Inhibitors Market Dynamics
2.5.1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Trends
2.5.2 Angiotensin Converting Enzyme (ACE) Inhibitors Market Drivers
2.5.3 Angiotensin Converting Enzyme (ACE) Inhibitors Market Challenges
2.5.4 Angiotensin Converting Enzyme (ACE) Inhibitors Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers by Sales (2017-2022)
3.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Manufacturers (2017-2022)
3.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Angiotensin Converting Enzyme (ACE) Inhibitors Sales in 2021
3.2 Global Top Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors by Revenue
3.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Manufacturers (2017-2022)
3.2.2 Top Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers Covered: Ranking by Revenue
3.2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiotensin Converting Enzyme (ACE) Inhibitors as of 2021)
3.4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Angiotensin Converting Enzyme (ACE) Inhibitors Market
3.7 Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Type
4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Review by Type (2017-2022)
4.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Type (2017-2022)
4.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Type (2017-2022)
4.1.3 Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2017-2022)
4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Type (2023-2028)
4.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast by Type (2023-2028)
4.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors Price Forecast by Type (2023-2028)
5 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Application
5.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Review by Application (2017-2022)
5.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Application (2017-2022)
5.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Application (2017-2022)
5.1.3 Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2017-2022)
5.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Application (2023-2028)
5.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast by Application (2023-2028)
5.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors Price Forecast by Application (2023-2028)
6 North America
6.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Company
6.1.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2017-2022)
6.1.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2017-2022)
6.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Type
6.2.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028)
6.2.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2017-2028)
6.3 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Application
6.3.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028)
6.3.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2017-2028)
6.4 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
6.4.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2017-2028)
6.4.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Company
7.1.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2017-2022)
7.1.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2017-2022)
7.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Type
7.2.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028)
7.2.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2017-2028)
7.3 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Application
7.3.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028)
7.3.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2017-2028)
7.4 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
7.4.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2017-2028)
7.4.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Company
8.1.1 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2017-2022)
8.1.2 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2017-2022)
8.2 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Type
8.2.1 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028)
8.2.2 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2017-2028)
8.3 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Application
8.3.1 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028)
8.3.2 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2017-2028)
8.4 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Region
8.4.1 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region
8.4.2 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Company
9.1.1 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2017-2022)
9.1.2 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2017-2022)
9.2 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Type
9.2.1 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028)
9.2.2 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2017-2028)
9.3 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Application
9.3.1 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028)
9.3.2 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2017-2028)
9.4 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
9.4.1 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2017-2028)
9.4.2 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Company
10.1.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2017-2022)
10.1.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2017-2022)
10.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Type
10.2.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028)
10.2.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2017-2028)
10.3 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Application
10.3.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028)
10.3.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2017-2028)
10.4 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
10.4.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2017-2028)
10.4.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.1.5 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors SWOT Analysis
11.1.6 Abbott Laboratories Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.2.5 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.3.5 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors SWOT Analysis
11.3.6 Novartis Recent Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Overview
11.4.3 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.4.5 Merck Angiotensin Converting Enzyme (ACE) Inhibitors SWOT Analysis
11.4.6 Merck Recent Developments
11.5 Astra Zeneca
11.5.1 Astra Zeneca Corporation Information
11.5.2 Astra Zeneca Overview
11.5.3 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.5.5 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors SWOT Analysis
11.5.6 Astra Zeneca Recent Developments
11.6 Jhonson and Johnson
11.6.1 Jhonson and Johnson Corporation Information
11.6.2 Jhonson and Johnson Overview
11.6.3 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.6.5 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors SWOT Analysis
11.6.6 Jhonson and Johnson Recent Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Overview
11.7.3 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.7.5 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors SWOT Analysis
11.7.6 Eli Lilly Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.8.5 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors SWOT Analysis
11.8.6 Sanofi Recent Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Corporation Information
11.9.2 Bristol-Myers Squibb Overview
11.9.3 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.9.5 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors SWOT Analysis
11.9.6 Bristol-Myers Squibb Recent Developments
11.10 Bayer
11.10.1 Bayer Corporation Information
11.10.2 Bayer Overview
11.10.3 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.10.5 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors SWOT Analysis
11.10.6 Bayer Recent Developments
11.11 GSK
11.11.1 GSK Corporation Information
11.11.2 GSK Overview
11.11.3 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.11.5 GSK Recent Developments
11.12 Teva Pharmaceutical
11.12.1 Teva Pharmaceutical Corporation Information
11.12.2 Teva Pharmaceutical Overview
11.12.3 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Products and Services
11.12.5 Teva Pharmaceutical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Angiotensin Converting Enzyme (ACE) Inhibitors Value Chain Analysis
12.2 Angiotensin Converting Enzyme (ACE) Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Angiotensin Converting Enzyme (ACE) Inhibitors Production Mode & Process
12.4 Angiotensin Converting Enzyme (ACE) Inhibitors Sales and Marketing
12.4.1 Angiotensin Converting Enzyme (ACE) Inhibitors Sales Channels
12.4.2 Angiotensin Converting Enzyme (ACE) Inhibitors Distributors
12.5 Angiotensin Converting Enzyme (ACE) Inhibitors Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Tables
Table 1. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Sulfhydryl-containing Agents
Table 3. Major Manufacturers of Dicarboxylate-containing Agents
Table 4. Major Manufacturers of Phosphonate-containing Agents
Table 5. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2017-2022) & (K MT)
Table 8. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Region (2017-2022)
Table 9. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Region (2017-2022)
Table 11. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Region (2023-2028) & (K MT)
Table 12. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Angiotensin Converting Enzyme (ACE) Inhibitors Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Angiotensin Converting Enzyme (ACE) Inhibitors Market Trends
Table 17. Angiotensin Converting Enzyme (ACE) Inhibitors Market Drivers
Table 18. Angiotensin Converting Enzyme (ACE) Inhibitors Market Challenges
Table 19. Angiotensin Converting Enzyme (ACE) Inhibitors Market Restraints
Table 20. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Manufacturers (2017-2022) & (K MT)
Table 21. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Manufacturers (2017-2022)
Table 22. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers by Revenue (US$ Million) in 2021
Table 24. Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Manufacturers (2017-2022)
Table 25. Global Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiotensin Converting Enzyme (ACE) Inhibitors as of 2021)
Table 27. Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Average Selling Price (ASP) & (2017-2022) & (USD/MT)
Table 28. Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Plants/Factories Distribution
Table 29. Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Area Served
Table 30. Date of Key Manufacturers Enter into Angiotensin Converting Enzyme (ACE) Inhibitors Market
Table 31. Key Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Type (2017-2022)
Table 34. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Type (2017-2022)
Table 35. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (K MT) by Type (2017-2022)
Table 37. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Type (2023-2028)
Table 38. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Type (2023-2028)
Table 39. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Type (2023-2028)
Table 41. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (K MT) by Type (2023-2028)
Table 42. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Application (2017-2022)
Table 43. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Application (2017-2022)
Table 44. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (K MT) by Application (2017-2022)
Table 46. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT) by Application (2023-2028)
Table 47. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Application (2023-2028)
Table 48. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Application (2023-2028)
Table 50. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price (K MT) by Application (2023-2028)
Table 51. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2017-2022) & (K MT)
Table 52. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Company (2017-2022)
Table 53. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Company (2017-2022)
Table 55. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2022) & (K MT)
Table 56. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2023-2028) & (K MT)
Table 57. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2022) & (K MT)
Table 60. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2023-2028) & (K MT)
Table 61. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2017-2022) & (K MT)
Table 64. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2023-2028) & (K MT)
Table 65. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2017-2022) & (K MT)
Table 68. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Company (2017-2022)
Table 69. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Company (2017-2022)
Table 71. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2022) & (K MT)
Table 72. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2023-2028) & (K MT)
Table 73. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2022) & (K MT)
Table 76. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2023-2028) & (K MT)
Table 77. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2017-2022) & (K MT)
Table 80. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2023-2028) & (K MT)
Table 81. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2017-2022) & (K MT)
Table 84. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2022) & (K MT)
Table 88. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2023-2028) & (K MT)
Table 89. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2022) & (K MT)
Table 92. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2023-2028) & (K MT)
Table 93. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2017-2022) & (K MT)
Table 96. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2023-2028) & (K MT)
Table 97. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2017-2022) & (K MT)
Table 100. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Company (2017-2022)
Table 101. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Company (2017-2022)
Table 103. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2022) & (K MT)
Table 104. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2023-2028) & (K MT)
Table 105. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2022) & (K MT)
Table 108. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2023-2028) & (K MT)
Table 109. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2017-2022) & (K MT)
Table 112. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2023-2028) & (K MT)
Table 113. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2017-2022) & (K MT)
Table 116. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2022) & (K MT)
Table 120. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2023-2028) & (K MT)
Table 121. Middle East and Africa Angiote

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group1976036

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Research Report 2023 An angiotensin-converting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure. Highlights The global Angiotensin Converting En...
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Insights, Forecast to 2029 This report presents an overview of global market for Angiotensin Converting Enzyme (ACE) Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and pro...
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Insights: Impact of COVID-19 and Future Expectations to 2028 The Angiotensin Converting Enzyme (ACE) Inhibitors market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, a...
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Research Report 2021, Forecast to 2026 Angiotensin-converting enzyme (ACE) inhibitors are medications that help relax the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme in the body from producing angiotensin II, a substance that narrows blood vessels. ...
Global Angiotensin Converting Enzyme (ACE) Inhibitors Professional Survey Report 2021, Forecast to 2026 Angiotensin-converting enzyme (ACE) inhibitors are medications that help relax the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme in the body from producing angiotensin II, a substance that narrows blood vessels. ...
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Insights and Forecast to 2028 Angiotensin Converting Enzyme (ACE) Inhibitors market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Angiotensin Converting Enzyme (ACE) Inhibitors market will be able to gain the upper hand as th...
Angiotensin Converting Enzyme (ACE) Inhibitors Market - Global Outlook and Forecast 2022-2028 An angiotensin-converting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure. This report contains market size and forecasts of Angi...
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Growth 2022-2028 As the global economy mends, the 2021 growth of Angiotensin Converting Enzyme (ACE) Inhibitors will have significant change from previous year. According to our (LP Information) latest study, the global Angiotensin Converting Enzyme (ACE) Inhibitors ...
(Post-pandemic Era) - Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Segment Research Report 2022 Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really rec...
Global and United States Angiotensin Converting Enzyme (ACE) Inhibitors Market Report & Forecast 2022-2028 Angiotensin Converting Enzyme (ACE) Inhibitors market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Angiotensin Converting Enzyme (ACE) Inhibitors market will be abl...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *